Quintiles Transitional Holdings Inc. (NYSE:Q) insider Kevin C. Knightly sold 19,339 shares of Quintiles Transitional Holdings stock in a transaction dated Friday, August 25th. The stock was sold at an average price of $99.51, for a total transaction of $1,924,423.89. Following the completion of the transaction, the insider now directly owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Quintiles Transitional Holdings Inc. (Q) opened at 95.79 on Thursday. The company’s 50-day moving average is $91.06 and its 200 day moving average is $84.68. Quintiles Transitional Holdings Inc. has a 12 month low of $70.10 and a 12 month high of $99.95. The company has a market capitalization of $20.74 billion, a price-to-earnings ratio of 277.65 and a beta of 0.64.

Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The business had revenue of $1.97 billion during the quarter, compared to analysts’ expectations of $1.96 billion. During the same quarter in the prior year, the business earned $0.93 earnings per share. The company’s quarterly revenue was up 68.7% compared to the same quarter last year. On average, equities research analysts anticipate that Quintiles Transitional Holdings Inc. will post $4.58 earnings per share for the current year.

Quintiles Transitional Holdings announced that its board has approved a stock buyback program on Wednesday, May 24th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the medical research company to reacquire up to 5.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: This story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/31/insider-selling-quintiles-transitional-holdings-inc-q-insider-sells-1924423-89-in-stock.html.

Several research firms have recently weighed in on Q. BidaskClub cut shares of Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a report on Friday, August 11th. Jefferies Group LLC reissued a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. William Blair raised shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $70.10 to $93.42 in a report on Friday, August 4th. Citigroup Inc. boosted their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the company a “neutral” rating in a report on Monday, August 7th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $92.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a report on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $90.25.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fiduciary Trust Co. acquired a new position in Quintiles Transitional Holdings during the second quarter valued at about $105,000. Korea Investment CORP boosted its position in Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after buying an additional 805 shares during the last quarter. GWM Advisors LLC acquired a new position in Quintiles Transitional Holdings during the second quarter valued at about $122,000. Global X Management Co. LLC boosted its position in Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after buying an additional 346 shares during the last quarter. Finally, IFP Advisors Inc boosted its position in Quintiles Transitional Holdings by 187.1% in the first quarter. IFP Advisors Inc now owns 1,774 shares of the medical research company’s stock valued at $143,000 after buying an additional 1,156 shares during the last quarter. Hedge funds and other institutional investors own 91.36% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Insider Buying and Selling by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.